This study also indicates that COX-2-derived PGs in the liver could be involved in the mechanism underlying the beneficial action against HFD-induced obesity and its associated impaired energy metabolism, inflammation, and insulin resistance by favoring lipid clearance in hepatocytes [11]. The gene discussed is PTGS2; the disease is obesity due to melanocortin 4 receptor deficiency.